SBC Medical Group Holdings Incorporated
Price Action
Technical Summary
EMERGING TRENDSBC Medical Group Holdings Incorporated is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings contraction of 48% provides fundamental context to the price action. However, price is extended 56% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.21 | +53.83% | ABOVE |
| 50 SMA | $0.20 | +55.71% | ABOVE |
| 100 SMA | $0.24 | +32.29% | ABOVE |
| 150 SMA | $0.22 | +45.71% | ABOVE |
| 200 SMA | $0.21 | +48.64% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SBCWW in an uptrend right now?
SBCWW has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is SBCWW overbought or oversold?
SBCWW's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.
Is SBCWW outperforming the market?
SBCWW has a Relative Strength (RS) Rating of 93 out of 99. Yes, SBCWW is a market leader, outperforming 93% of all stocks over the past 12 months.
Where is SBCWW in its 52-week range?
SBCWW is trading at $0.32, which is 80% of its 52-week high ($0.40) and 73% above its 52-week low ($0.10).
How volatile is SBCWW?
SBCWW has a Beta of 0.58 and 52-week volatility of 217%. It's less volatile than the S&P 500 - generally more stable.